A Phase 1, Open-Label, Single Oral Dose Study to Assess the Safety, Pharmacokinetics and Effect of Food on the Pharmacokinetics of Mirabegron (YM178) in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2011
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- 11 Oct 2011 Actual end date (June 2011) added as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Apr 2011 New trial record